Lombard Odier Asset Management (USA)’s Vertex Pharmaceuticals VRTX Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-651	Closed	-$255K	–	434
2025 Q3	$255K	Buy	+651	New	+$272K	0.02%	388
2021 Q4	–	Sell	-41,690	Closed	-$7.56M	–	429
2021 Q3	$7.56M	Buy	41,690 +33,596	+415%	+$6.56M	0.33%	51
2021 Q2	$1.63M	Buy	+8,094	New	+$1.69M	0.06%	151
2020 Q3	–	Sell	-7,500	Closed	-$2.18M	–	303
2020 Q2	$2.18M	Sell	7,500 -4,200	-36%	-$1.14M	0.15%	141
2020 Q1	$2.78M	Buy	+11,700	New	+$2.68M	0.29%	96

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s VRTX Position: Q4 2025 in Review

Lombard Odier Asset Management (USA) sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 651 shares — an estimated $255K sold.

Lombard Odier Asset Management (USA) first reported a position in VRTX in Q1 2020 and held it in 5 quarters. The position peaked at $7.56M in Q3 2021. 1,670 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Lombard Odier Asset Management (USA) reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 651 Vertex Pharmaceuticals shares in Q4 2025, an estimated $255K.
Lombard Odier Asset Management (USA) first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 5 quarters.
Lombard Odier Asset Management (USA)'s Vertex Pharmaceuticals position peaked at $7.56M in Q3 2021.
1,670 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2025, filed 17 Feb 2026.